Related Tags >> Phase III FDA Biotech Venture Capital Drug Trials

Phase II News

Most Popular Phase II Story

J&J's prostate cancer drug proves promising in Ph2

February 17, 2010 — 10:38am ET | By John Carroll

A mid-stage trial for abiraterone--an oral drug which inspired a billion-dollar buyout less than a year ago--has produced another set of promising results for men with advanced, treatment-resistant Read more...

Phase II Press Releases

ChemoCentryx Reports Clinical Efficacy for CCX354, a Novel CCR1 Inhibitor in a Phase II Study in Patients with Rheumatoid Arthri
Tengion to Host Conference Call to Provide a Business Update and Report Third Quarter 2011 Financial Results on November 14, 201
Furiex Acquires Full Exclusive License to MuDelta for the Treatment of Diarrhea-Predominant IBS and Reports Positive End o
Microalgae Foods Pioneer, Solazyme Roquette Nutritionals, Announces Manufacturing Facility in Lestrem, France
SIRO Clinpharm and Peregrine Pharmaceuticals Highlight Successful Collaboration

Latest Headlines

Adverse events force Conatus to shelve PhII study of lead HCV therapy
October 26, 2011
Ph2 Roche study delivers promising long-term ocrelizumab data on MS
October 20, 2011
UPDATED: Sangamo scuttles lead drug program after it fails PhIIb
October 3, 2011
AstraZeneca flunks Ph2 lung cancer trial with drug from Array BioPharma
September 30, 2011
Roche HDL drug dalcetrapib clears a crucial safety test
August 28, 2011
Peregrine shares spike on Ph2 cancer data
August 24, 2011
Roche preps vismodegib app with "profound" efficacy data
June 29, 2011
Alder lands $15M milestone from blockbuster BMS antibody deal
June 20, 2011
Roche preps vismodegib app after Ph2 skin cancer success
June 20, 2011
Exelixis shares slide as CEO cheers a mid-stage prostate cancer success
June 7, 2011
UPDATED: ASCO roundup: Fresh progress of Merck, Pfizer cancer drugs
June 6, 2011
Developers find that Phase II hurdle is getting harder to clear
May 10, 2011
Xoma shares blitzed after lead drug flunks key diabetes study
March 23, 2011
Struggling XenoPort shelves GERD program after Ph2b failure
March 21, 2011
Pfizer's tasocitinib for psoriasis shows Phase II promise
October 7, 2010
Ardea shares spike on promising PhIIb gout drug data
April 1, 2010
J&J's prostate cancer drug proves promising in Ph2
February 17, 2010
Geron stem cell therapy promising in the lab
January 6, 2010
Icagen shares plunge on failed asthma trial
October 27, 2009
Oxford BioMedica surges on Parkinson's trial success
October 15, 2009

Paid Research Reports

More Research Reports >>